CMN-005 by CoImmune for B-Cell Non-Hodgkin Lymphoma: Likelihood of Approval

CMN-005 is under clinical development by CoImmune and currently in Phase II for B-Cell Non-Hodgkin Lymphoma.

GE HealthCare partners with J&J to push spine imaging system

Dive Brief: GE HealthCare has formed a distribution agreement with Johnson & Johnson to increase use of its OEC 3D Imaging System. The applications of

June 22, 2023

Opinion | Why Don’t Men Have Their Version of ‘The Pill’?

Pauling is a mother, a DEI executive, and a former civil rights litigator. Last fall, my first-year University of Miami daughter came to me with

May 1, 2024

Hotter days in New York linked to spike in substance abuse hospital visits

New study finds a positive correlation between rising temperatures and increased hospital visits for alcohol and substance-related disorders in New York State. The research suggests

September 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.